"10.1371_journal.pone.0106810","plos one","2014-09-04T00:00:00Z","Christoph Kraus; Pia Baldinger; Christina Rami-Mark; Gregor Gryglewsky; Georg S Kranz; Daniela Haeusler; Andreas Hahn; Wolfgang Wadsak; Markus Mitterhauser; Dan Rujescu; Siegfried Kasper; Rupert Lanzenberger","Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine Medical University of Vienna, Vienna, Austria; Department of Psychiatry, Medical University of Halle, Halle, Germany","Conceived and designed the experiments: RL SK DR WW MM CK. Performed the experiments: CK PB CRM GG GSK DH AH. Analyzed the data: CK GG GSK AH. Contributed reagents/materials/analysis tools: DH WW MM DR RL SK. Contributed to the writing of the manuscript: CK PB CRM GG GSK DH AH WW MM DR SK RL.","Without any relevance to this work, S. Kasper declares that he has received grant/research support from Eli Lilly, Lundbeck A/S, Bristol-Myers Squibb, Servier, Sepracor, GlaxoSmithKline, Organon, and has served as a consultant or on advisory boards for AstraZeneca, Austrian Sick Found, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lily, Lundbeck A/S, Pfizer, Organon, Sepracor, Janssen, and Novartis, and has served on speakers bureaus for AstraZeneca, Eli Lilly, Lundbeck A/S, Servier, Sepracor and Janssen. R. Lanzenberger has received travel grants and conference speaker honoraria from AstraZeneca, Lundbeck A/S and Roche Austria GmbH. C. Kraus and P. Baldinger have received travel grants and conference speaker honoraria from Roche. G.S. Kranz received travel grants from Roche and AOP Orphan. W. Wadsak has received research support from Rotem GmbH, ABX, Iason, Advion and Raytest Austria and has served as a consultant/trainer for Bayer and THP. The authors M. Mitterhauser, C. Rami-Mark, and A. Hahn report no financial relationships with commercial interests.","2014","09","Christoph Kraus","CK",12,TRUE,6,7,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
